The French brand is luring interest from both strategics and investment funds, sources say.
There is growing industry buzz that the French dermocosmetics brand, which has taken off both at home and abroad, could be sold as early as year-end. Both strategics and investment funds have shown interest, sources say.
Coline Bertrand and Manhault de Guilbert – two pharmacist friends from university – launched La Rosée in 2015. The brand has subsequently built a cult following.
“We wanted to create a brand with ultra-natural products – up to 100 percent of natural origin – eco-responsible and ultra-healthy, without controversial ingredients,” Bertrand explained in a WWD interview in 2024. Other key elements from the outset were having a universal range with affordable price points, which average 14 euros.
La Rosée launched with five products and now has more than 40, including baby care and hair care. Its refillable deodorant and sun care stick are the brand’s top sellers.
As health, wellbeing and beauty converge, dermocosmetics is the fastest-growing category within the skin care segment. It is currently a $54.41 billion business, which is estimated to reach $80.29 billion in 2031, representing an annual growth rate of 8.1 percent, according to Mordor Intelligence.
Most recently, Puig took a minority stake in French dermocosmetics brand Krème in a funding round led by Iris Ventures this July. Meawhile, L’Oréal and Beiersdorf’s dermocosmetics activities keep accelerating.
La Rosée first hit the market in 300 pharmacies in France , and now it’s in upward of 9,500.
Source link
